ARAbraham Reichenberg

Abraham Reichenberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Abraham Reichenberg has a total of 326 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Eye-Tracking as an Objective Phenotyping Tool for Environmental Epidemiology: A Pilot Study of Prenatal Metal Mixtures Exposure and Social Perception

    by Elza Rechtman, Anna Sather, Hannah Wheless, Kristie Oluyemi, Azzurra Invernizzi, Michelle A. Rodriguez, Abraham Reichenberg, Libni A. Torres-Olascoaga, Luis Bautista-Arredondo, Sandra Martinez-Medina, et al.

    Social cognition begins with the perception of socially relevant information conveyed through others' eyes and faces. Epidemiological studies of social cognition have relied primarily on caregiver- and self-reported measures, which may not capture subtle alterations in the biological processes underlying social cognition. In this pilot study, we used eye-tracking as an objective measure of spontaneous gaze behavior to examine associations between prenatal metal mixture exposure and social perception, an early component of social cognition, during adolescence. Thirty-nine adolescents (median age 13.1 years [8.4–15.3], 51% female) completed a naturalistic eye-tracking paradigm of short videos showing peer-to-peer social interactions. Dynamic areas of interest were drawn around characters' eyes, and gaze fixation duration was recorded using a Tobii Pro Fusion eye tracker. Generalized weighted quantile sum (gWQS) regression was used to examine associations between participants’ prenatal exposure to a mixture of copper (Cu), manganese (Mn), lead (Pb), and zinc (Zn) and fixation duration to the eyes, as well as questionnaire-based measures of social cognition. Higher prenatal metal mixture exposure, driven primarily by Mn (39%), was significantly associated with reduced fixation to the eyes (β = -24.8, 95% CI [-46.4, -3.2]), whereas no associations were observed with questionnaire-based measures of social cognition. These findings support eye-tracking as an observer-independent tool to detect environmentally related alterations in social perception that may not be captured by conventional questionnaire-based assessments and underscore the need to integrate objective behavioral phenotyping into environmental epidemiology.

  • Open Access

    Course of head growth from birth to adolescence across the psychosis spectrum

    by Sarah A. Ashley, Kate Merritt, Francesca Solmi, Pedro Luque Laguna, Yanakan Logeswaran, Derek K. Jones, David Linden, Anthony S. David, Abraham Reichenberg

    Background: Charting developmental abnormalities in future psychotic disorder could help identify pathogenic processes. Head circumference (HC) is a proxy for brain size. Studies of HC and its developmental trajectories in future psychotic disorder cases and across the psychosis spectrum are inconclusive. It is important to determine whether deviations in HC are specific or reflect a general growth disorder. Methods: We used data from the Avon Longitudinal Study of Parents and Children (ALSPAC) to chart HC trajectories from birth to 15 years in individuals with operationally-defined psychotic disorder (N = 62), psychotic experiences (PE; N = 339) and controls (N = 3,527). We extracted total intracranial volume (TIV) from MRI data on a subset (N = 347) scanned at age 20. Results: HC at birth, 7 and 15 years was correlated with TIV at age 20 (r’s = 0.45–0.77). The psychotic disorder group had consistently smaller HC from birth through to adolescence (B = −0.26, p = 0.02). Females with PE had smaller HC across childhood and adolescence (B = −0.27, p = 0.016), while males with PE had consistently larger HC (B = 0.35, p = 0.023). The effects did not change when controlling for maternal and pregnancy-related characteristics but attenuated after controlling for height, except in males with PE. Conclusions: Deviations in head and hence brain size across the psychosis spectrum likely reflect a more general growth abnormality. Future studies should examine factors regulating growth during early life in relation to psychosis, including sex, to understand underlying mechanisms.

  • Open Access

    Long‐Term Risk of Rheumatoid Arthritis in Individuals With Autism Spectrum Disorder: A Population‐Based Matched Cohort Study

    by Evora Hailin Zhu, Stephen Z. Levine, Matilda Morin, Weiyao Yin, Benjamin Christoffersen, Johan Askling, Natalia Rivera, Abraham Reichenberg, Joseph D. Buxbaum, Sven Sandin, et al.

    To investigate the long‐term risk of rheumatoid arthritis (RA) among individuals with autism spectrum disorder (ASD), addressing potential immune comorbidity in ASD populations. A population‐based matched cohort was assembled using Swedish registers, including 46,164 individuals diagnosed with ASD between 1987 and 2017, matched to 4,634,895 controls by sex and birth year. Cohort members were followed from age 18 until RA diagnosis, death, emigration, or end of follow‐up, providing up to 30 years of observation into adulthood. Cox proportional hazards models estimated hazard ratios (HR) for RA, with sensitivity analyses adjusting for parental autoimmune, psychiatric history, and socioeconomic status. RA diagnosis rates were similar between individuals with ASD ( n = 58, 0.13%) and controls ( n = 5484, 0.12%), with no increased risk: overall HR = 1.06 (95% CI 0.82–1.37), seropositive HR = 1.00 (0.67–1.48), and seronegative HR = 1.12 (0.79–1.57). Complementary analyses adjusting for parental psychiatric history, autoimmune conditions, and socioeconomic factors yielded consistent null findings (HR = 1.34, 95% CI 0.97–1.84). Sensitivity analyses, including accelerated failure time models and alternative RA subtype definitions, confirmed these results. This large‐scale population study does not suggest an increased RA risk in individuals with ASD. Despite suggested immune dysfunction in ASD and shared genetic pathways with autoimmune conditions, we did not observe evidence that ASD is associated with elevated RA risk during adulthood; In conclusion, these findings inform understanding of autoimmune comorbidity patterns in autism and may guide evidence‐based clinical monitoring for autistic adults.

  • Cross-Setting Replication of the Associations Between Maternal Health and Autism

    by Vahe Khachadourian, Meredith Anderson, Elias Speleman Arildskov, Jakob Grove, Abraham Reichenberg, Sven Sandin, Diana Schendel, Stefan Nygaard Hansen, Lisa A. Croen, Magdalena Janecka


  • Open Access

    Domain-specific cognitive function in euthymic bipolar disorder: a systematic review and meta-analysis

    by Samuel Swidzinski, Dimosthenis Tsapekos, Pricilla Swidzinska, Wenjia Zhang, Moxun Zheng, Edward Millgate, Rebecca Strawbridge, Roxanna Short, Ben Carter, Peter Gallagher, et al.

    Background: Euthymic bipolar disorder (BD) is associated with general and domain-specific cognitive impairment, which predicts poor occupational and social functioning. Methods: We searched Embase, Medline, and PsycInfo for articles published between database inception and June 2024, examining cognitive domains in euthymic BD. We conducted meta-analysis, meta-regressions, including premorbid IQ, demographic, and clinical variables. Newcastle Ottawa Scale, I 2 statistic, and funnel plots/Egger’s and Begg’s Test were used to assess quality, heterogeneity, and publication bias, respectively. The Benjamini-Hochberg (BH) procedure was utilised for multiple comparisons. Results: We identified 95 groups from 75 studies ( N = 4,404 BD & 4,037 HC). BD showed significant impairment in general cognitive functioning (Hedge’s g = −0.58, 95%CI: −0.79, −0.37, p <.01), verbal memory (Hedge’s g = −0.70, 95%CI: −0.79, −0.60, p <.01), executive function (Hedge’s g = −0.69, 95%CI: −0.78, −0.60, p <.01), visuo-spatial memory (Hedge’s g = −0.68, 95%CI: −0.83, −0.53, p <.01), attention/processing speed (Hedge’s g = −0.64, 95%CI: −0.75, −0.54, p <.01), working memory (Hedge’s g = −0.61, 95%CI: −0.74, −0.49, p <.01), and premorbid IQ (Hedge’s g = −0.24, 95%CI: −0.36, −0.12, p <.01). Demographic and clinical factors were not associated with cognitive performance, except for a statistically significant, but small positive correlation between years of education and lower impairment in verbal memory, β = .066, adjusted p <.05. Conclusions: Our findings highlight cognitive domains impaired in euthymic BD, indicating targets for interventions. Substantial variance is unexplained, warranting focus on larger samples of individual-level data.


  • Open Access

    Maternal medication use in pregnancy and offspring ASD risk: A prescription-wide, target-informed study

    by Nina Zaks, Arad Kodesh, Nicole Zatorski, Yifan Wang, Stephen Z. Levine, Sven Sandin, Abraham Reichenberg, Avner Schlessinger, Magdalena Janecka

    Background: Certain prescription drugs used during pregnancy are associated with offspring autism spectrum disorder (ASD). Nonetheless, ASD risk following prenatal exposure to most drugs remains unknown. Furthermore, methodological challenges and ethical concerns hinder the scope for causal inference. Methods: We used a case-cohort study design of a nationally representative sample from Israel to examine the associations between maternal prescription drug use during pregnancy and offspring ASD. To scrutinize these associations, the analyses were (a) adjusted for indication proxy (level 2 Anatomical Therapeutic Chemical (ATC) codes), (b) repeated using shared pharmacological targets as exposures, and (c) inspected further through target-enrichment analysis. Results: The sample included 1,400 individuals with and 94,713 without an ASD diagnosis. Among all drugs prescribed during pregnancy, five were statistically significantly associated with increased offspring ASD risk after adjustment for indication proxy (e.g., hazard ratio [95% confidence interval] cyproterone = 2.71 [1.17–6.25] and prednisolone = 2.10 [1.27–3.49]), and two with decreased risk (ferrous sulfate = 0.82 [0.68, 0.99] and lynestrenol = 0.43 [0.2, 0.93]). Further analysis revealed four pharmacological targets shared by these drugs, which were themselves associated with ASD (e.g., neuronal acetylcholine receptor α4β4 = 1.45 [1.05–1.99] and serotonin 2b receptor = 1.31 [1.04–1.61]). Enrichment analysis suggested the association between ASD and medications affecting cholinergic and serotonergic signaling. Conclusions: Increased ASD risk followed prenatal exposure to five prescription drugs, and decreased risk followed exposure to two. Subsequent analyses suggested no confounding by indication in these associations, but further studies are warranted.


  • A new perspective on the causal pathway between maternal mental health and neonatal adversity

    by Emma Lin, Elah Wilson, Arad Kodesh, Stephen Z. Levine, Abraham Reichenberg, Nathan Fox, Nina Zaks, Magdalena Janecka

    Purpose Substantial evidence suggests a downstream impact of maternal mental health on birth outcomes. The roles of comorbid maternal physical health and familial confounding underlying this association remain unclear. Methods This cohort study included a random sample of children born 1997–2008 within a health maintenance organization (HMO) in Israel, their parents, and siblings. Outcomes were ICD-9 diagnoses of neonatal adversities (birth complications and congenital anomalies) and exposures were maternal diagnoses of mental health disorders. Odds ratios (ORs) and their 95% confidence intervals for the associations between maternal mental health diagnoses and measures of neonatal adversity were calculated using logistic regression, adjusting for maternal age, child’s year of birth, socioeconomic status, and maternal physical morbidity burden. We examined potential familial confounding using a negative control approach based on paternal exposure. Results In our sample of 74,533 children, 6,674 (9.1%) were born after birth complications and 14,569 (19.9%) with a congenital anomaly. Maternal mental health diagnosis around pregnancy was significantly associated with these measures of neonatal adversity after adjustment for potential confounders (birth complications: OR = 1.3 (1.2–1.4), p < 0.001; congenital anomalies: OR = 1.2 (1.1–1.3), p < 0.001). These associations became attenuated and non-significant after further adjustment for maternal physical morbidity burden. In a joint model, maternal and paternal diagnosis of a mental health disorder were independently associated with neonatal adversity (birth complications: ORmat=1.3 (1.1–1.4), p < 0.001; ORpat=1.2 (1.1–1.3), p = 0.004; congenital anomalies: ORmat=1.2 (1.1–1.3), p < 0.001; ORpat=1.1 (1.0-1.2), p = 0.01). Conclusion Physical health and familial factors play a role in the associations between maternal mental health and neonatal adversity.

  • Open Access

    Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder

    by Nora I. Strom, Zachary F. Gerring, Marco Galimberti, Dongmei Yu, Matthew W. Halvorsen, Abdel Abdellaoui, Cristina Rodriguez-Fontenla, Julia M. Sealock, Tim Bigdeli, Jonathan R. Coleman, et al.

    Obsessive-compulsive disorder (OCD) affects ∼1% of children and adults and is partly caused by genetic factors. We conducted a genome-wide association study (GWAS) meta-analysis combining 53,660 OCD cases and 2,044,417 controls and identified 30 independent genome-wide significant loci. Gene-based approaches identified 249 potential effector genes for OCD, with 25 of these classified as the most likely causal candidates, including WDR6, DALRD3, CTNND1 and multiple genes in the MHC region. We estimated that ∼11,500 genetic variants explained 90% of OCD genetic heritability. OCD genetic risk was associated with excitatory neurons in the hippocampus and cortex, along with D1- and D2-type dopamine receptor-containing medium spiny neurons. OCD genetic risk was shared with 65 of 112 additional phenotypes, including all of the psychiatric disorders we examined. In particular, OCD shared genetic risk with anxiety, depression, anorexia nervosa, and Tourette syndrome, and was negatively associated with inflammatory bowel diseases, educational attainment, and body mass index.


  • Open Access

    Somatic comorbidities of mental disorders in pregnancy

    by Vahe Khachadourian, Arad Kodesh, Stephen Z. Levine, Emma Lin, Joseph D. Buxbaum, Veerle Bergink, Sven Sandin, Abraham Reichenberg, Magdalena Janecka

    Background: Mental and physical health conditions are frequently comorbid. Despite the widespread physiological and behavioral changes during pregnancy, the pattern of comorbidities among women in pregnancy is not well studied. This study aimed to systematically examine the associations between mental and somatic disorders before and during pregnancy.Method: The study used data from mothers of a nationally representative birth cohort of children born in Israel (1997–2008). We compared the risk of all major somatic disorders (International Classification of Diseases, Ninth Revision) in pregnant women with and without a mental disorder. All analyses were adjusted for maternal age, child’s birth year, family socioeconomic status, and the total number of maternal encounters with health services around pregnancy period.Results: The analytical sample included 77,030 mother–child dyads, with 30,083 unique mothers. The mean age at child’s birth was 29.8 years. Prevalence of diagnosis of mental disorder around pregnancy in our sample was 4.4%. Comorbidity between mental and somatic disorders was two times higher than the comorbidity between pairs of different somatic disorders. Of the 17 somatic disorder categories, seven were positively associated with mental health disorders. The highly prevalent comorbidities associated with mental disorders in pregnancy included e.g. musculoskeletal (OR = 1.30; 95% CI = 1.20–1.42) and digestive system diseases (OR = 1.23; 95% CI = 1.13–1.34).Conclusions: We observed that associations between maternal diagnoses and mental health stand out from the general pattern of comorbidity between nonmental health diseases. The study results confirm the need for screening for mental disorders during pregnancy and for potential comorbid conditions associated with mental disorders.


  • Open Access

    Biopsychosocial exposure to the COVID-19 pandemic and the relative risk of schizophrenia: Interrupted time-series analysis of a nationally representative sample

    by Yael Travis-Lumer, Arad Kodesh, Yair Goldberg, Abraham Reichenberg, Sophia Frangou, Stephen Z. Levine

    Background: Studies of COVID-19 pandemic biopsychosocial exposure and schizophrenia risk showed contradictory results, were undertaken early in the pandemic, and did not consider lockdowns or COVID-19 infection. Hence, we examined the association between COVID-19 biopsychosocial exposure and incident schizophrenia.Methods: An interrupted time-series study design was implemented based on Israeli electronic health records from 2013 to 2021 with national coverage. The period coinciding with the COVID-19 pandemic biopsychosocial exposures from March 2020 to February 2021 was classified as exposed, otherwise unexposed. The effect of the COVID-19 pandemic on incident schizophrenia was quantified by fitting a Poisson regression and modeling the relative risk (RR) and corresponding 95% confidence intervals (CI). Three scenarios were projected from the third lockdown to 10 months to forecast incident schizophrenia rates and their associated 95% prediction intervals (PI).Results: The total population (N = 736,356) yielded 4,310 cases of incident schizophrenia over time. The primary analysis showed that the period exposed to the COVID-19 pandemic was associated with a reduced RR (RR = 0.81, 95% CI = 0.73, 0.91, p < 0.001). This conclusion was supported in 12 sensitivity analyses, including scrutinizing lockdowns and COVID-19 infection status. Two of three forecast scenarios projected an incident increase (6.74, 95% PI = 5.80, 7.84; 7.40, 95% PI = 6.36, 8.60).Conclusions: The reduced risk of schizophrenia during the pandemic suggests no immediate triggering of new onsets either by the virus or the pandemic-induced psychosocial adversities. Once restrictions are lifted, the increased projected presentations have implications for clinicians and healthcare policy.